05.11.2020 • NewsCelanese

Celanese Expands UHMW-PE Capacity in USA

Celanese will add a new line at its plant in Bishop, Texas, USA, for its GUR brand of ultra-high molecular weight polyethylene (UHMW-PE) to support significant market growth. The new line will add about 15,000 t/y of capacity by the start of 2022.

UHMW-PE microporous membranes are used as separators in lithium-ion batteries, demand for which will grow significantly in Europe and Asia over the next five years, said Celanese, because of the explosive growth in global electric vehicle sales.

“Electric vehicle demand is expected to have a compounded annual growth rate of greater than 25% through 2025, resulting in strong demand for Celanese GUR for lithium-ion battery separators,” said Tom Kelly, senior vice president, engineered materials, adding that Celanese is committed to investing further in local manufacturing capabilities to offer “unmatched security of supply.”

In June last year, the company completed a project at Nanjing, China, that also lifted GUR capacity by about 15,000 t/y.

Author: Elaine Burridge, Freelance Journalist

Celanese will add a new line at its plant in Bishop, Texas, USA, for its GUR...
Celanese will add a new line at its plant in Bishop, Texas, USA, for its GUR brand of ultra-high molecular weight polyethylene (UHMW-PE) to support significant market growth. The new line will add about 15,000 t/y of capacity by the start of 2022. (c) Celanese

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.